AT
Insider
Arthur Tzianabos
Interim Executive ChairArthur Tzianabos (Interim Executive Chair) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $174K of STOK (4,355 sh × $40.00, as filed), executed Mar 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$174K
shares × price, as filed
Last traded
Mar 10
Filed Mar 12
Median ADV $25.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $174K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
STOKRecent filings
STOKSALE
Stoke Therapeutics, Inc.
View filing →
$174K4,355 sh × $40.00
Exec Mar 10
Filed Mar 12 · 5:30 PM ET